UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008399 |
|---|---|
| Receipt number | R000009882 |
| Scientific Title | Clinical trial to evaluate efficacy and safety of cyclophosphamide, bortezomib and dexamethasone (CBD) induction and autologous stem cell transplantation for patients for newly diagnosed multiple myeloma (NBMT-ASCT1201) |
| Date of disclosure of the study information | 2012/07/23 |
| Last modified on | 2022/03/10 16:18:44 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/07/11 10:01:55 | ||
| 2 | Update | 2013/04/02 22:25:39 | Recruitment status |
|
| 3 | Update | 2015/01/20 23:41:14 | Email Address Address TEL |
|
| 4 | Update | 2015/12/08 15:56:21 | Recruitment status |
|
| 5 | Update | 2018/07/17 17:19:56 | Email Name of primary person or sponsor Institute Institute Department Organization Organization1 Institutions |
|
| 6 | Update | 2019/03/26 10:11:37 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email1 Tel2 Email2 Tel3 Email3 Organization Organization Address Address Tel |
|
| 7 | Update | 2019/03/26 10:21:10 | Date of IRB Last follow-up date |
|
| 8 | Update | 2019/03/26 10:29:27 | Number of participants that the trial has enrolled |
|
| 9 | Update | 2020/01/15 21:30:51 | Date of closure to data entry |
|
| 10 | Update | 2020/01/15 21:40:48 | Name of person sending information Name of person sending information Division name Division name |
|
| 11 | Update | 2022/03/10 16:18:44 | Recruitment status Date trial data considered complete Date analysis concluded |
